Health Care Counsel Blog

852 total results. Page 1 of 35.

D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Elizabeth Satarov, Apeksha Vora

Headlines that Matter for Companies and Executives in Regulated Industries

Jill A. Steinberg, Gayland O. Hethcoat II

As of December 23, health care providers, health plans, and health care clearinghouses (covered entities) and their business associates (collectively, regulated entities) must comply with new reproductive health care privacy protections under the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule. Enforcement will begin against the backdrop of a pending lawsuit challenging the validity of the new protections and an incoming Trump Administration with an uncertain enforcement posture.

D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, M.H. Joshua Chiu, Elizabeth Satarov

Headlines that Matter for Companies and Executives in Regulated Industries

D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, M.H. Joshua Chiu, Rebekkah R.N. Stoeckler

Headlines that Matter for Companies and Executives in Regulated Industries

D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Mattie Bowden, Rebekkah R.N. Stoeckler

Headlines that Matter for Companies and Executives in Regulated Industries

Stephanie Trunk, Shoshana Golden

This past July, we reported on the Centers for Medicare & Medicaid Services (CMS) release of the 2025 proposed Hospital Outpatient Prospective Payment System (HOPPS) and Physician Fee Schedule (PFS) rules. CMS has now released the 2025 final rules, though they will not be published in the Federal Register for several more weeks.

D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Mattie Bowden, Heather M. Zimmer

Headlines that Matter for Companies and Executives in Regulated Industries

D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, John M. Hindley, Heather M. Zimmer

Headlines that Matter for Companies and Executives in Regulated Industries

Douglas A. Grimm, Shira Helstrom, Craig Engle, Cameron Custard

On October 28, the US Court of Appeals for the Fifth Circuit held that a nonprofit corporation that coordinates health care for privately insured patients does not qualify for tax exemption under Section 501(c)(4) because it is not “operating exclusively for the promotion of social welfare.”

Anne M. Murphy, Stephen Blake

How Massachusetts senior living providers need to be thinking about the recently enacted Long Term Care Reform Law and a recent Centers for Medicare & Medicaid Services audit of nursing homes.

D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, John M. Hindley, Laura Zell

Headlines that Matter for Companies and Executives in Regulated Industries

D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Rebecca W. Foreman, Laura Zell

Headlines that Matter for Companies and Executives in Regulated Industries

D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Rebecca W. Foreman, Roberto Martinez

Headlines that Matter for Companies and Executives in Regulated Industries

Gayland O. Hethcoat II, M.H. Joshua Chiu

In a significant move toward regulating artificial intelligence (AI) in health care, Assembly Bill (AB) 3030 will require health facilities, clinics, and physician practices in California to provide disclaimers to patients about their use of generative AI (GenAI).

Debra Albin-Riley, Lowell C. Brown, M.H. Joshua Chiu

Expanding on the peer review protections established in Bonni v. St. Joseph Health System, the California Court of Appeal in Dignity Health v. Mounts held that a wide array of medical staff communications regarding peer review and patient care are absolutely protected from legal liability.

D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Shoshana Golden, Roberto Martinez

Headlines that Matter for Companies and Executives in Regulated Industries

D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Mattie Bowden, Shoshana Golden, John M. Hindley

Headlines that Matter for Companies and Executives in Regulated Industries

Thomas E. Jeffry, Jr., Gayland O. Hethcoat II

On September 28, California Governor Gavin Newsom vetoed Assembly Bill (AB) 3129. The proposed law sought to regulate health care transactions involving private equity and hedge funds.

D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Mattie Bowden, Elizabeth Satarov

Headlines that Matter for Companies and Executives in Regulated Industries

D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Rebekkah R.N. Stoeckler, Elizabeth Satarov

Headlines that Matter for Companies and Executives in Regulated Industries

Caroline Turner English, Alison Lima Andersen, Pascal Naples, Mattie Bowden

On September 9, the US Departments of Labor, Treasury, and Health and Human Services (the Departments) jointly released a final rule to ensure that group health plans comply with the Mental Health Parity and Addiction Equity Act (MHPAEA).

D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Roberto Martinez, Rebekkah R.N. Stoeckler

Headlines that Matter for Companies and Executives in Regulated Industries

D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Roberto Martinez, Heather M. Zimmer

Headlines that Matter for Companies and Executives in Regulated Industries

Douglas A. Grimm, Stephanie Trunk, Gayland O. Hethcoat II, Shoshana Golden

In 2021, we provided an overview of multiple federal lawsuits challenging the US Department of Health and Human Services (HHS) Health Resources and Services Administration’s (HRSA) enforcement of the 340B Drug Pricing Program, particularly with respect to contract pharmacies.

Michael K. Molzberger, Linda M. Jackson, Matthew F. Prewitt, Alexandra M. Romero, Lauren C. Schaefer

On August 20, the US District Court for the Northern District of Texas held that the Federal Trade Commission’s (FTC) final rule banning noncompetes is unlawful and “set aside” the rule.